Obesity is highly prevalent among blacks and is associated with a greater risk of heart failure (HF). However, the contribution of regional adiposity depots such as visceral adipose tissue (VAT) and abdominal subcutaneous adipose tissue toward risk of HF in blacks is unknown.
B
lacks have a higher burden of metabolic risk factors, as well as heart failure (HF) compared with other races. [1] [2] [3] [4] Obesity is one such risk factor that is increasing in prevalence among blacks and is associated with a greater risk of HF. 5 However, obesity is a heterogeneous and complex condition that consists of regional adipose tissue depots, as well as lean body mass. Prior studies have demonstrated that regional adipose depots, such as visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), have differential contributions toward cardiovascular risk factor development. VAT has been shown to have more pathogenic cardiometabolic effects in epidemiological cohort studies and is more strongly associated with traditional cardiovascular risk factors, metabolic syndrome, and abnormalities in cardiac structure and function. [5] [6] [7] [8] [9] [10] This has been largely attributed to the metabolically active nature of the visceral adipose compartment, with greater production and release of inflammatory cytokines, adipokines, and other growth factors into the systemic circulation. 11, 12 However, the contributions of regional adipose tissue depots toward abnormalities in left ventricle (LV) structure and function and downstream risk of clinical HF in blacks are not well-established.
In this study, we evaluated the association of quantitative measures of specific adipose tissue depots (VAT and SAT) with measures of LV structure and function and risk of incident HF among black participants of the Jackson Heart Study (JHS) cohort.
METHODS

Study Population
The authors will not make their data, analytic methods, and study materials available to other researchers. Requests to access the data set from qualified researchers may be sent to the JHS data coordinating center. The JHS is a prospective, population-based cohort study of individuals from Jackson, MS, established in 2000 to study cardiovascular disease (CVD) in blacks. The cohort characteristics, study protocol, and data collection have been previously reported. 6, 13 Briefly, a total of 5306 individuals, 21 to 84 years of age, were enrolled in the JHS from various sources, including 31% previously enrolled in the ARIC study (Atherosclerosis Risk in Communities), 17% from random sampling of participants from three counties around Jackson, 30% volunteer sample, and 22% family members of enumerated household. Participants were seen at an initial clinic visit (visit 1: 2000-2004) at which time surveys, anthropometric and vital measurements, laboratory testing, and imaging studies were performed. Participants were invited to return for 2 subsequent visits (visit 2: 2005-2008; visit 3: 2009-2013) for additional data collection. Annual follow-up was performed by contacting participants via telephone to obtain updated information about interim medical events and hospitalizations. In the present study, we included a subset of participants from the second JHS visit who underwent multidetector computed tomography (CT) scanning of the abdomen for assessment of VAT and SAT depots.
14 Of the 4203 participants who attended the second JHS visit (2005) (2006) (2007) (2008) , the following were excluded from CT examination: (1) body weight >350 pounds; (2) those who were pregnant or had an unknown pregnancy status; (3) age <40 years for women and <35 years for men. Among those without prevalent HF, quantitative measurements of VAT were available in 2882 participants, of which 280 were further excluded with missing follow-up. The final study population included 2602 participants. All participants provided written informed consent. The Institutional Review Board of University of Mississippi Medical Center, Jackson State University, and Tougaloo College approved this study.
Volumetric Measures of VAT and SAT by Multidetector CT Scan
Primary exposure variables for our study were the quantitative volumetric measures of regional adipose tissue depots, specifically VAT and SAT. Details about assessment of VAT and SAT have been published previously. 6 Briefly, during visit 2, a 16-channel multidetector CT with cardiac gating (Lightspeed 16 Pro; GE Healthcare, Milwaukee, WI) was used to scan the heart and lower abdomen. The acquired CT imaging slices covering the abdominal region from L5 to S1 was used to assess VAT and SAT. The protocol used 24 contiguous slices, 2 mm thick, surrounding the center of the L4-L5 spine with 12 slices both above and below, to quantify VAT and SAT. Each individual voxel was characterized as tissue attenuation of fat using volume analysis software (Advantage Windows; GE
WHAT IS NEW
• The contribution of regional adipose tissue depots toward heart failure (HF) risk in blacks is not well established. In this study, we observed that higher amounts of visceral adiposity were associated with higher risk of HF among blacks.
• This association was largely driven by differences in traditional HF risk factor burden.
• In contrast, higher measures of overall adiposity, measured as body mass index, was associated with higher risk of HF independent of traditional HF risk factor burden and amount of visceral adipose tissue.
WHAT ARE THE CLINICAL IMPLICATIONS
• Findings from our study suggest that contributions of visceral adiposity toward HF risk in blacks are largely related to differences in traditional risk factor burden.
• These findings suggest that aggressive modification of traditional risk factors among may be a useful strategy to lower the risk of HF associated with higher amounts of visceral adiposity among blacks.
Healthcare, Waukesha, WI), with a threshold range of −190 to −30 Hounsfield units. The VAT and SAT volumes were the sum of VAT and SAT voxels over 24 slices. VAT and SAT were reported as volume in cm 3 . The CT Reading Center in the Wake Forest School of Medicine was responsible for quality control and interpretation of the imaging. The interclass correlation coefficient for inter-read comparisons, in a random sample of 60 participants, was 0.95 for VAT and SAT.
Measures of Obesity and Other Covariates
Weight (in kg) was measured using a balance scale. Height (in cm) was measured with a vertical ruler. Body mass index (BMI) was calculated by dividing participant weight in kilograms by height in meters squared. Covariates reported in the JHS cohort that have been previously shown to influence the risk of incident HF, 15 such as age, sex, systolic blood pressure, prevalent hypertension, antihypertensive medications, prevalent diabetes mellitus (DM), hemoglobin A1c, BMI, and prevalent CVD, were all included in the analysis.
Select demographic factors, including age and sex, were based on self-report during the baseline interview. Sitting blood pressure was calculated as the average of 2 resting blood pressure recordings. Prevalent hypertension was defined as a systolic blood pressure ≥140 mm Hg, a diastolic blood pressure ≥90 mm Hg, or the use of blood pressure lowering medications. Prevalent DM was defined as having a fasting glucose ≥126 mg/dL, hemoglobin A1c ≥6.5%, or use of DM medications. Prevalent CVD was defined by self-reported myocardial infarction or percutaneous coronary intervention or ECG findings consistent with myocardial infarction. Prevalent HF at second baseline visit was defined using the modified Gothenburg criteria developed and validated in the ARIC dataset and applied to the JHS cohort.
16,17
Cardiac Magnetic Resonance Parameters for LV Structure and Function
Cardiac magnetic resonance imaging was completed on visit 3 using a 1.5-T magnetic resonance imaging system (Siemens Espree; Siemens, Erlangen, Germany; 70 cm bore, advanced cardiac package, TIM Matrix surface coil) and this protocol was based on the previously described Multiethnic Study of Atherosclerosis cardiac magnetic resonance protocol. 18 Cine images with steady-state free precession were gated by ECG to assess LV function and mass. Short axis volumetric coverage was used to obtain LV volume and mass. Papillary muscles were excluded from LV mass but included in LV volumes. Analysis of cardiac structure and function data was performed using Cardiac Image Modeler software (University of Auckland, New Zealand). Tagged images of the basal, mid, and apical LV walls were performed using a cine radiofrequency grid-tagging sequence (field of view 400 mm, slice thickness 8 mm, 192×256 matrix, repetition time 60 ms, echo time 4 s, and fractional anisotropy of 12° [Siemens sequence: Tl2d1r5]). A harmonic phase algorithm (Diagnosoft, Morrisville, NC) was used to complete the myocardial tagging analysis. Finally, global strain was computed by using the average peak circumferential strain of the apical, mid, and basal walls of the LV.
Clinical Outcomes of Interest
The primary outcome of interest was incident HF, and the secondary outcome was a composite of incident HF and all-cause mortality. The protocol used for adjudication of HF events in the JHS has been described previously. 19 Incident HF hospitalizations were identified through annual follow-up telephone interviews and confirmed with HF hospitalization records. The formal adjudication of HF events in the JHS started in January 2005 and was performed by trained medical personnel using abstracted data from hospital medical records and autopsy reports. HF hospitalization definitions were based on symptoms, physical findings, and diagnostic procedures.
Statistical Analysis
For the present analysis, the study population was stratified into data derived tertiles of VAT and SAT. Baseline demographic, clinical, and laboratory data from visit 2 (visit for VAT and SAT assessment) were reported across the study groups as median (25th to 75th percentile) for continuous variables and percentages (%) for categorical variables. Jonckheere trend test and Wilcoxon-rank-sum test were used to compare the continuous and categorical variables across the tertiles of VAT and SAT. The association between measures of VAT, SAT, and cardiac magnetic resonance measures of LV structure and function at visit 3 were assessed in a subset of the study population (N=1128) using multivariable-adjusted linear regression models with adjustment for age, sex, BMI, history of hypertension, history of DM, systolic blood pressure, use of antihypertensive medications, hemoglobin A1c, and history of CVD. VAT and SAT were included in separate models for each of the following LV parameter outcome of interest: LV mass, LV end-diastolic volume (EDV), LV stroke volume, LV ejection fraction (EF), LV concentricity (LV mass/LVEDV), and LV peak systolic circumferential strain. The unadjusted risk of HF across tertiles of VAT were assessed using Kaplan-Meier plots and log-rank tests. Multivariable-adjusted Cox proportional hazard analyses were performed to determine the associations of VAT and SAT amounts with risk of incident HF.
The proportional hazard assumption was tested for the Cox models using the scaled Schoenfeld residuals. Associations of continuous and categorical measures of VAT and SAT with the outcomes of interest were assessed in separate models with sequential adjustment for the following confounders: model 1: age, sex; model 2: model 1 + traditional HF risk factors (hypertension, DM, A1c, systolic blood pressure, antihypertensive medications, prevalent CVD); model 3: model 2 + BMI. All covariates included in the adjusted Cox (for incident HF) and linear regression (for magnetic resonance imaging parameter outcomes) models were measured at the visit of VAT and SAT assessment (visit 2).
Several sensitivity analyses were performed to assess the robustness of our study findings. First, owing to the large number of deaths in the cohort, sensitivity analyses were performed evaluating the association between VAT, BMI, and risk of HF while accounting for death as a competing risk. Second, additional Cox models were also constructed to evaluate the association between VAT and risk of HF with adjustment for allometric height instead of BMI as a measure for body size. Third, we also assessed the association between amount of VAT normalized to SAT (VAT/SAT ratio) with risk of HF after adjustment for potential confounders. Finally, the independent contribution of different adiposity parameters toward HF risk was also evaluated by constructing additional Cox models and including VAT, SAT, and BMI in the same model along with other HF risk factors. The analysis was performed using SAS Statistical Software (version 9.1, SAS Institute, Cary, NC).
RESULTS
The final study population included 2602 participants. The baseline characteristics for the study participants are compared across tertiles of VAT and SAT in Table 1 and Table I in the Data Supplement, respectively. Participants with higher amount of VAT were older and more commonly men. In contrast, participants with higher amount of SAT were younger and more commonly women. The prevalence of traditional cardiovascular risk factors such as hypertension and DM was greater across increasing tertiles of VAT and SAT, with a more apparent gradi- 
Association Between BMI, Regional Adipose Depot, and Cardiac Structure and Function
Among participants with VAT and cardiac MRI assessments (N=1128), those with higher amounts of VAT had higher LV mass, higher LV concentricity, and worse LV strain. No significant differences were noted in LVEF and LVEDV across VAT tertiles in unadjusted comparisons (Table 2 ). In the multivariable-adjusted linear regression analysis, higher amounts of VAT were associated with lower LVEDV, higher LV concentricity, and worse LV peak systolic circumferential strain (Table 3) . VAT was not associated with LV mass or LVEF in adjusted analyses. In contrast, there was a consistent, strong association between higher BMI and measures of adverse LV remodeling such as higher LV mass, higher LVEDV, and worse LV strain. SAT was not associated with measures of LV structure and function in adjusted analyses.
Association Between BMI, Regional Adipose Depot, and Risk of HF
There were 122 incident HF events and 166 death events observed over the median follow-up of 7.1 years (IQR: 6.5 to 8.1 years). In the unadjusted analysis, higher amounts of VAT were significantly associated with higher risk of HF (Figure, P-log rank <0.0001, Table II in the Data Supplement). Proportional hazards assumption was satisfied for the Cox models using the scaled Schoenfeld residuals. In adjusted Cox proportional hazards analysis, higher amounts of VAT (continuous as well as tertiles) were associated with higher risk of HF on follow-up after adjustment for age and sex (Table 4 , model 1). This association was substantially attenuated and no longer significant after further adjustment for other HF risk factors and BMI (Table 4 , models 2 and 3). Similar findings were observed when BMI was replaced by allometric height as a covariate for body size (Table  III in the Data Supplement). In contrast, higher BMI was significantly associated with higher risk of HF in the most adjusted model that accounted for other HF risk factors and VAT (Table 5 ). In sensitivity analysis accounting for death as a competing risk, the patterns of association between VAT, BMI, and risk of HF were similar to that noted in the primary analysis (Table IV in 
DISCUSSION
We observed several important findings in this study of community-dwelling blacks. Higher amounts of VAT were associated with higher risk of HF hospitalization. However, these associations were largely driven by differences in risk factor burden and were no longer significant after adjustment for prevalent HF risk factors. In contrast, higher BMI was consistently associated with higher risk of HF independent of traditional risk factors and VAT. Furthermore, higher BMI was more consistently and strongly associated with abnormal cardiac remodeling patterns with higher LV mass, LV dilation, and worse LV strain than measures of regional adipose depot tissue depot such as VAT and SAT after accounting for traditional HF risk factors. Finally, SAT was not associated with risk of HF hospitalization. Taken together, our study findings suggest that among community-dwelling blacks, higher burden of visceral adiposity may contribute to Data presented as median and interquartile range or %. EDV indicates end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricle; MRI, magnetic resonance imaging; Strain, peak systolic circumferential strain; and VAT, visceral adipose tissue.
Figure. Cumulative incidence plot comparing the risk of heart failure hospitalization across tertiles of visceral adipose tissue amount. a higher risk of HF through higher burden of traditional cardiovascular risk factors.
To our knowledge, the present study is the first to assess the association between regional adipose tissue depots and risk of HF among blacks. Prior studies have demonstrated that anthropometric measures of obesity (BMI), as well as central adiposity (waist circumference) are associated with higher risk of HF. 20, 21 However, the contribution of quantitative measures of regional adiposity such as VAT and SAT toward risk of HF is less well-established. In a cohort of older black and white participants from the Health, Aging, and Body Composition study, VAT was associated with higher risk of HF in partially adjusted models that include demographic characteristics, smoking status, and chronic obstructive pulmonary disease (hazard ratio per 1-SD higher VAT area: 1.25 [1.08-1.45]). 22 However, the associations between VAT and risk of HF were not significant after further adjustment for traditional HF risk factors (hazard ratio per 1-SD higher VAT area: 1.07 [0.86-1.33]). Higher amounts of VAT are associated with higher burden of prevalent, as well as incident cardiometabolic risk factors such as hypertension and DM. 6, 7, 9, 13, 23 This association may be related to the metabolically active nature of VAT that leads to dysregulation of fat metabolism and a proinflammatory state. 24, 25 The higher burden of cardiometabolic risk factors associated with high amounts of VAT may be the key mediator of higher risk of HF. Thus, the association between VAT and HF attenuates with adjustment for these risk factors, as noted by Nicklas et al 22 in the Health, Aging, and Body Composition Separate linear regression models for VAT and SAT exposure variables and for each LV parameter (outcome) with adjustment for age, sex, prevalent hypertension, prevalent diabetes mellitus, systolic blood pressure, HgbA1c, history of CVD, BMI, and BP medications. Standardized estimates for BMI are derived from linear regression models that included VAT and other traditional risk factors. Standardized estimate represents change in the outcome of interest (in SD) per 1-SD increase in the primary exposure variable keeping other covariates fixed. BMI indicates body mass index; CMR, cardiac magnetic resonance imaging; EDV, end-diastolic volume; EF, ejection fraction; LV, left ventricle; SAT, subcutaneous adipose tissue; Strain, peak systolic circumferential strain; and VAT, visceral adipose tissue. All covariates included in the adjusted models were measured at the visit of VAT and SAT assessment (visit 2). Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, HF risk factors (history of hypertension, diabetes mellitus, systolic blood pressure, antihypertensive medications, hemoglobin A1c, and history of CVD). Model 3: adjusted for age, sex, HF risk factors (history of hypertension, diabetes mellitus, systolic blood pressure, BP meds hemoglobin A1c, and history of CVD), and BMI. Separate models were created for continuous and categorical exposures of VAT (2 models) and SAT (2 models). BP indicates blood pressure; CVD, cardiovascular disease; HF, heart failure; HR, hazard ratio; SAT, subcutaneous adipose tissue; and VAT, visceral adipose tissue. study cohort and in the present analysis among the JHS participants.
It is noteworthy that prior studies from multiethnic cohorts have demonstrated that higher amounts of VAT are associated with intermediate LV phenotypes such as concentric hypertrophy, myocardial fibrosis, and higher LV stiffness that are implicated in development of heart failure with preserved ejection fraction (HFpEF). 10, [26] [27] [28] [29] We also observed that higher amounts of VAT were significantly associated with smaller LV size, higher LV concentricity, lower strain but not with systolic dysfunction.
Consistent with this observation, a recent analysis from the Multiethnic Study of Atherosclerosis suggests that central adiposity and higher amounts of VAT may be preferentially associated with risk of HFpEF but not HF with reduced EF (HFrEF) through upregulation of systemic inflammatory pathways. 30 This is particularly relevant because in blacks the lifetime risk of HFpEF is lower than that observed in other races and the incident HF events are more likely to be HFrEF than HFpEF (61% versus 29% in the ARIC surveillance cohort). 31, 32 It is plausible that the lack of association between VAT and risk of HFrEF, the predominant incident HF phenotype in blacks, may have contributed to the observed null association between VAT and overall HF in our study cohort of community-dwelling blacks. We also observed that SAT, another regional adipose tissue depot, was not associated with HF risk. These findings are also consistent with prior observations from the literature and highlight the heterogeneity in the contributions of regional adipose tissue depots toward abnormal cardiovascular and metabolic phenotypes. 6, 8, 9, 13 SAT may serve as a depot to store fat, curtailing the accumulation of visceral fat and subsequently avoiding its downstream cardiometabolic complications. 33 Unlike regional adiposity depots, overall obesity measured as BMI was significantly associated with higher risk of HF in blacks independent of other HF risk factors, as well as VAT. Furthermore, compared with VAT and SAT, higher BMI was more consistently and strongly associated with abnormal cardiac remodeling patterns that may predispose to both HFpEF and HFrEF, including higher LV mass, greater concentricity, and worse LV strain, which corroborates prior studies evaluating BMI and LV function in blacks. 34 Several factors may underlie the observed VAT independent association between BMI and risk of HF. Higher levels of BMI are associated with greater hemodynamic stress, increased neurohormonal activation, decreased LV adaptability because of increased fibrosis, LV hypertrophy, LV dilation, and endothelial dysfunction. These effects may be independent of VAT, as suggested in recent studies implicating other regional fat depots such as pericardial fat in development of CVD. 25 Furthermore, recent studies have implicated higher lean body mass in development of chronic CVD such as atrial fibrillation independent of other adiposity metrics. 35, 36 Higher lean body mass has also been associated with higher prevalence of HF in the Women's Health Initiative cohort. 35 Considering the overlap in risk factors for atrial fibrillation and HF and in light of our study findings, future studies are needed to better understand how lean body mass may impact risk of HF. Higher BMI-related risk of HF may also be related to lower cardiorespiratory fitness among obese individuals. 37 Prior studies have demonstrated that lower cardiorespiratory fitness levels are strongly associated with higher risk of HF, particularly among obese individuals. 37 Owing to the lack of cardiorespiratory fitness level assessment in the JHS, the contribution of obesity toward HF risk, independent of cardiorespiratory fitness levels could not be assessed.
Our study findings have important clinical and public health implications. Rates of incident HF are higher in individuals with higher amount of VAT. Furthermore, central adiposity in patients with established HF, particularly HFpEF, is associated with worse clinical outcomes. 38 Findings from our study suggest that the contribution of VAT toward HF risk in blacks is related to the coexisting high burden of traditional HF risk factors. Future studies are needed to determine whether aggressive modification of traditional HF risk factors among black individuals with high amounts of VAT may attenuate their risk of HF. Our study findings also suggest that overall obesity, as measured by BMI, is an independent risk factor for HF, and thus, is an important target for HF prevention among blacks, who tend to have less VAT compared with whites. 39 Interventions focused on weight loss such as bariatric surgery and caloric restrictions have been shown to lower the risk of HF and improve key outcomes in patients with established HF. [40] [41] [42] [43] It remains to be seen if interventions targeting overall weight loss may significantly modify risk of HF in blacks independent of changes in regional adiposity distribution.
Our study has several important limitations. First, owing to the observational nature of our analysis, the study findings may be predisposed to residual confounding. Second, we do not have data on incidence of HF subtypes namely, HFpEF and HFrEF, in this cohort. As a result, we could not assess the differential association of VAT and SAT with these 2 HF subtypes. Third, since only participants <350 pounds underwent CT evaluation, the most obese participants were not included in the analysis. Fourth, we do not have measures of other regional adipose tissue depot such as pericardial fat, liver fat, or lower body fat. Thus, we cannot evaluate the contributions of these adipose tissue depots on the risk of HF. Finally, the JHS included only black participants and our study findings are not generalizable to other ethnic groups.
In conclusion, higher amounts of VAT may identify black individuals with higher risk of HF, largely because of higher burden of traditional HF risk factors. In contrast, overall obesity as measured by BMI is significantly associated with risk of HF in blacks, independent of the other HF risk factors, and VAT. Future studies are needed to confirm these observations and understand the contribution of regional fat depots other than VAT, such as pericardial fat and lower body fat, and lean body mass toward risk of HF in blacks. 
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